Email Updates

You are here

AVAC's Blog: P-Values

  • This 10-week interactive and online course will help researchers and clinical trial stakeholder to apply the Good Participatory Practice (GPP) Guidelines in their unique settings. In this unprecedented time, sustaining effective partnerships is more crucial than ever before. This course provides a personalized learning experience, global knowledge, tools to advance GPP implementation in diverse contexts and access to GPP experts and professional networks.

    June 12, 2020
    General
    AVAC
  • Black Lives Matter.

    The Black lives of AVAC’s staff, partners and friends matter. The Black lives of those who live near our office in Harlem matter. The Black lives of those on the streets across the United States and around the world calling for justice and equity matter. It’s more important than ever to say these fundamental truths.

    June 2, 2020
    AVAC
  • The AVAC team is united in sorrow and anger at the inequities that are being laid bare in America today. We advocate every day for an equitable HIV response, but we know that we can’t stop there. We stand with those who are calling for a more just and equitable world.

    May 30, 2020
    AVAC
  • In case you missed it, AVAC has a number of new resources to support our collective advocacy for HIV prevention research and an equitable, evidence-based response to COVID-19.

    May 29, 2020
    AVAC
  • We have the benefit of history to provide a clear vision of what must happen with COVID-19. We stand on the shoulders of giants in the fight against HIV who never took “no” for an answer: advocates who demanded a vaccine because they knew their lives depended on it. At the same time, they acted as if a vaccine would never arrive, thereby accelerating the development and delivery of safe and effective treatment and prevention options.

    May 29, 2020
    Mitchell Warren
  • The COVID-19 pandemic demands that everyone apply their skills, resources and networks to empower communities and ease collective suffering.

    May 21, 2020
    Daisy Ouya
  • In this time of COVID-19, new information and new questions arise daily with implications for global health advocacy and for the HIV response at large. In the midst of this, HIV research has taken some major steps forward as well. AVAC has produced a number resources to keep you informed and guide your advocacy on all these issues.

    May 21, 2020
    AVAC
  • We are writing with breaking PrEP news—data now show that bi-monthly injections of long-acting cabotegravir (CAB-LA) appears to be safe and effective in preventing HIV in cisgender men and transgender women who have sex with men.

    May 18, 2020
    AVAC
  • This HIV Vaccine Awareness Day a global audience is fixated on the need for vaccines. The COVID-19 pandemic has people struggling to understand the science, the development process and the necessity of a vaccine. Taking in these lessons is no less vital for HIV. AVAC’s new report, Five “P”s to Watch: Platforms, process, partnerships, payers and participatory practices that drive vaccine development, connects these key issues and lays out how HIV vaccine research is making the search for a COVID-19 vaccine faster, smarter and more inclusive.

    May 18, 2020
    AVAC
  • A new episode of AVAC’s Px Pulse podcast is ready for download! We take a comprehensive look at the intersection of HIV and COVID-19.

    May 14, 2020
    AVAC

Pages